Because available data on cystatin C-based GFR equation remain very limited, and measurement of cystatin C is inexpensive and easily available, the possible use of serum cystatin C as a marker for risk of poor coronary collateralization would be desirable and clinically meaningful in the management of stable coronary artery disease patients. Here, CST3 is linked to coronary artery disorder.